• Register
  • Login
International Pharmacy Acta
  • Home
  • Journal Info
    • About
    • Focus and Scope
    • Ownership & Management
    • Indexing
    • Editorial Team
  • New Submission
  • Author Guidelines
    • Guideline
    • Types of articles
    • Templates
    • Publication Fees
  • Policies and Process
    • Peer Review Process
    • Open Access Policy
    • plagiarism
    • Archiving
    • Privacy Statement
    • Copyright Notice
    • Waiver policy
    • Complaints Policy
    • Post- Publication Discussions and Corrections Policy
    • Advertisement and Marketing
  • Issues
    • Current
    • Archives
  • Contact us
Advanced Search
  1. Home
  2. Archives
  3. Vol. 1 No. 2 (2018): International Pharmacy Acta
  4. Original Research article

ISSN: 2645-3258

International Pharmacy Acta
Vol. 1 No. 2 (2018)

Novel Synthetic Derivatives of Dichloroimidazole Targeting NorA Efflux Pump against Methicillin-Resistant Staphylococcus aureus

  • Maryam Salehi
  • Mohsen Amini
  • Shima Aliebrahimi
  • Sajad Ghadbeigi
  • Mahshid Kiani
  • Zahra Yahyavi
  • Seyed Nasser Ostad

International Pharmacy Acta, Vol. 1 No. 2 (2018), , Page 167-175
https://doi.org/10.22037/ipa.v1i2.21152 Published 17 June 2018

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Introduction:


Antibiotic resistance has been a major health problem in recent years, which has led to a failure in the treatment of infectious diseases. Therefore, research to synthesize compounds that have antibiotic activity is very valuable. In present study four novel compounds (6a-d), derivatives of dichloroimidazole conjugated with triazole, were synthesized in order to obtain new bacterial efflux pump inhibitors (EPIs).


Methods and Results:


The derivatives were evaluated for their effects on the minimum inhibitory concentration (MIC) of ciprofloxacin against a methicillin and ciprofloxacin resistant Staphylococcus aureus (MCRSA) clinical isolate. Based on broth microdilution method assay, four derivatives at a minimum effective concentration (MEC) fortified the antibacterial efficacy of ciprofloxacin against MCRSA. MIC of ciprofloxacin decreased in the presence of novel compounds compared to ciprofloxacin alone between 2 to 64 fold. These compounds were then evaluated for their potency as efflux pump inhibitors using a fluorometric assay. Results indicated an increase in accumulation of ethidium bromide (a known fluorescent substrate for the NorA pump) in the presence of each compound, like verapamil (a typical inhibitor of efflux pump), thus these compounds acted as inhibitors of the NorA pump. Moreover, the MTT assay confirmed that novel compounds did not demonstrate any cytotoxic effect against three cancer cell lines, HT-29, MCF-7 and Caco-2, and a normal mouse fibroblastic cell line, NIH-3T3.


Conclusion:


Collectively, our results propose these derivatives as therapeutic options in combination therapies to tackle antibiotic resistance.


Grants: This research has been supported by Grant Number 94-02-33-29506 from Deputy of Research, Tehran University of Medical Science.

Keywords:
  • Synthesis
  • Triazoles
  • Antibacterial activity
  • Cytotoxic activity
  • Inhibitors
  • PDF
  • XML

How to Cite

Salehi, M., Amini, M., Aliebrahimi, S., Ghadbeigi, S., Kiani, M., Yahyavi, Z., & Ostad, S. N. (2018). Novel Synthetic Derivatives of Dichloroimidazole Targeting NorA Efflux Pump against Methicillin-Resistant Staphylococcus aureus. International Pharmacy Acta, 1(2), 167-175. https://doi.org/10.22037/ipa.v1i2.21152
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 685 times
  • PDF Downloaded: 182 times
  • XML Downloaded: 67 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram
Open Journal Systems
Make a Submission
Keywords
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License.

 

                                                  Online ISSN: 2645-3266

                                                  Print ISSN: 2645-3258                                                 

The template of this website is designed by Sinaweb